Recent successes in heart failure treatment

CSP Lam, KF Docherty, JE Ho, JJV McMurray… - Nature Medicine, 2023 - nature.com
Remarkable recent advances have revolutionized the field of heart failure. Survival has
improved among individuals with heart failure and a reduced ejection fraction and for the …

Iron metabolism in cardiovascular disease: physiology, mechanisms, and therapeutic targets

KT Sawicki, A De Jesus, H Ardehali - Circulation research, 2023 - Am Heart Assoc
The cardiovascular system requires iron to maintain its high energy demands and metabolic
activity. Iron plays a critical role in oxygen transport and storage, mitochondrial function, and …

Pig-to-human heart xenotransplantation in two recently deceased human recipients

N Moazami, JM Stern, K Khalil, JI Kim, N Narula… - Nature medicine, 2023 - nature.com
Genetically modified xenografts are one of the most promising solutions to the discrepancy
between the numbers of available human organs for transplantation and potential recipients …

Randomized trial of left bundle branch vs biventricular pacing for cardiac resynchronization therapy

Y Wang, H Zhu, X Hou, Z Wang, F Zou, Z Qian… - Journal of the American …, 2022 - jacc.org
Background Left bundle branch pacing (LBBP) is the most rapidly growing conduction
system pacing technique that is capable of correcting intrinsic left bundle branch block …

Development and validation of the American Heart Association's PREVENT equations

SS Khan, K Matsushita, Y Sang, SH Ballew… - Circulation, 2024 - Am Heart Assoc
BACKGROUND: Multivariable equations are recommended by primary prevention
guidelines to assess absolute risk of cardiovascular disease (CVD). However, current …

[HTML][HTML] Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice

F Xue, J Cheng, Y Liu, C Cheng, M Zhang… - … and Targeted Therapy, 2022 - nature.com
Abstract Angiotensin-converting enzyme 2 (ACE2) has proven beneficial in attenuating
diabetic cardiomyopathy (DCM) but has been found to be a substrate of a disintegrin and …

Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis

P Ponikowski, RJ Mentz, AF Hernandez… - European Heart …, 2023 - academic.oup.com
Abstract Background and Aims Whereas a beneficial effect of intravenous ferric
carboxymaltose (FCM) on symptoms and exercise capacity among patients with iron …

Practical algorithms for early diagnosis of heart failure and heart stress using NT‐proBNP: A clinical consensus statement from the Heart Failure Association of the …

A Bayes‐Genis, KF Docherty, MC Petrie… - European Journal of …, 2023 - Wiley Online Library
Diagnosing heart failure is often difficult due to the non‐specific nature of symptoms, which
can be caused by a range of medical conditions. Natriuretic peptides (NPs) have been …

Efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction according to age: the DELIVER trial

A Peikert, FA Martinez, M Vaduganathan… - Circulation: Heart …, 2022 - Am Heart Assoc
Background: The prevalence of heart failure with mildly reduced or preserved ejection
fraction markedly increases with age, with older individuals disproportionately facing excess …

Angiotensin-neprilysin inhibition in patients with mildly reduced or preserved ejection fraction and worsening heart failure

RJ Mentz, JH Ward, AF Hernandez, S Lepage… - Journal of the American …, 2023 - jacc.org
Background US guidelines recommend consideration of sacubitril/valsartan in chronic heart
failure (HF) and mildly reduced or preserved ejection fraction (EF). Whether initiation is safe …